(Doxorubicin HCl Liposome Injection 2 mg/ml)
•Doxorubicin HCl is a drug used in cancer chemotherapy. Doxorubicin is commonly used in the treatment of a wide range of cancers, including hematological malignancies, many types of carcinoma, and soft tissue sarcomas. Doxorubicin’s most serious adverse effect is life-threatening heart damage, which limits its application. Therefore, various efforts have been made to reduce its side effects, including encapsulating it in nanoparticle systems such as nanoliposomes. The nano-liposomal form of doxorubicin HCl (Doxil®/Caelyx®) has entered the global market during the past few years by the approval of FDA.